Fusion Pharmaceuticals
chief scientific james chief medical officer officer fusion lead program targeted alpha therapeutic | Fusion Pharmaceuticals
Company
Deck Type
IPO
Sector
Industry
Deck date
June 2020
Slide
16 of 49
Similar slides by Fusion Pharmaceuticals
See diffirences between slides (animation)
IPO
June 2020
james chief medical officer clinical strategy and data | Fusion Pharmaceuticals
Related slides by other companies
Alkermes
Investor Day
March 2021
tumor targeted split fusion protein program principal scientist research oncology | Alkermes
Aravive
Investor Presentation
September 2022
developing transformative targeted cancer therapeutics | Aravive
Aravive
Investor Presentation
September 2022
developing transformative targeted cancer therapeutics | Aravive
Other recent decks by Fusion Pharmaceuticals
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
November 2023
Investor Presentation
August 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights